SPECIFIC PHARMA A/S: Financial statements 2024
CVR: 33161395
Source: annual report 2024, Danish Business Authority
01/02/2023 – 31/01/2024
SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 210,987,000 and a net result of DKK 25,560,000 compared with DKK 9,876,000 the year before. That is an increase of 18.8% compared with the year before. The profit margin was 12.1%. Equity in the 2024 report amounted to DKK 106,245,000. The solvency ratio was 84.2%. The company had 25 employees in the financial year.
- Revenue
- DKK 210,987,000
- Gross Profit
- DKK 48,547,000
- Profit/Loss
- DKK 25,560,000
- Equity
- DKK 106,245,000
- Total Assets
- DKK 126,169,000
- Employees
- 25
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 211 mio. | 48.5 mio. | 25.6 mio. | 106.2 mio. | 25 |
| 2023 | 177.6 mio. | 34.7 mio. | 9.9 mio. | 89.6 mio. | 25 |
| 2022 | 123.3 mio. | 26.4 mio. | 7.8 mio. | 85.5 mio. | 23 |
| 2021 | 139.6 mio. | 32.5 mio. | 14.8 mio. | 88.8 mio. | 21 |
| 2020 | 128.2 mio. | 27 mio. | 8.2 mio. | 80.2 mio. | 16 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout SPECIFIC PHARMA A/S
SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The board consists of Kristine Sakstrup Haag (chair), Henrik Kaastrup, Kasper Casparij Yde and Ken Rasmussen. The company is owned by NOMECO A/S. The company has 24 employees (2018). In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity in the 2026 report amounted to DKK 98,645,000.